임상

HOME > 연구실적 > 임상 > 논문
 
작성일 : 16-03-13 21:02
논문번호 30
논문제목(영문) The clinical effects of the BiodivYsio Phosphorylcholine-coated Stent in patients with small coronary artery diseases.
국내외구분 국내 SCI여부 KCI
연구책임자역할 교신저자
주저자명 Hong YJ
교신저자명 Jeong MH
공동저자명 Hong YJ, Jeong MH, Shim DS, Lim SY, Yang BR, Lee SH, Lee SH, Park OY, Park WS, Kim JH, Choi MJ, Kim IS, Kim W, Ahn Y, Cho JG, Park JC, Kang JC;
게제년월일 2002-03-01
ISSN 1738-9364
Impact Factor 0
학술지명 The Korean Journal of Medicine
서지사항 0집 / 63권 / 3호,   페이지(251 - 260)
요약초록문
(Abstract) 입력		 Background : The BiodivYsio stent is a balloon-expandable stent coated with phosphorylcholine designed to reduce the formation of thrombus and the risk of restenosis.
Methods : We prospectively studied 20 patients who underwent implantation of BiodivYsio stent (group I; 60.8±}9.3 years, male 60.0%) and compared to 20 patients who underwent balloon angioplasty alone (group II; 60.3±}7.9 years, male 45.0%) for small coronary arterial lesions (target arterial diameter was between 2.0 mm and 2.8 mm) between February 2001 and October 2001. Major adverse cardiac events such as acute myocardial infarction, target vessel revascularization and death were evaluated during hospital admission and at 6-months after percutaneous coronary intervention (PCI).
Results : During hospitalization, the incidence of acute myocardial infarction, target vessel revascularization and death was not different between the two groups. At follow-up coronary angiography 6 months after PCI, the incidence of restenosis was lower in group I than in group II (Group I; 3/20, 15.0% vs Group II; 9/20, 45.0%, p=0.032) and the incidence of target vessel revascularization (TLR) was lower in group I than in group II (Group I; 3/20, 15.0% vs Group II; 8/20, 40.0%, p=0.041).
Conclusion : Coronary BiodivYsio stenting in small coronary artery leads to excellent short- and mid-term clinical outcomes.
파일  C30.+Korean+Med+J+2002;63(3)251-260..pdf (341.2K) DATE : 2021-05-21 16:19:53